191 related articles for article (PubMed ID: 25489300)
21. Transcatheter Closure of Patent Foramen Ovale: A Single Center Experience.
Milev I; Zafirovska P; Zimbakov Z; Idrizi S; Ampova-Sokolov V; Gorgieva E; Ilievska L; Tosheski G; Hristov N; Georgievska-Ismail L; Anguseva T; Mitrev Z
Open Access Maced J Med Sci; 2016 Dec; 4(4):613-618. PubMed ID: 28028400
[TBL] [Abstract][Full Text] [Related]
22. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
23. Coincidental Impact of Transcatheter Patent Foramen Ovale Closure on Migraine with and without Aura - A Comprehensive Meta-Analysis.
Kanwar SM; Noheria A; DeSimone CV; Rabinstein AA; Asirvatham SJ
Clin Trials Regul Sci Cardiol; 2016 Mar; 15():7-13. PubMed ID: 26949743
[TBL] [Abstract][Full Text] [Related]
24. Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.
Alushi B; Lauten A; Cassese S; Colleran R; Schüpke S; Rai H; Schunkert H; Meier B; Landmesser U; Kastrati A
Clin Res Cardiol; 2018 Sep; 107(9):788-798. PubMed ID: 29644412
[TBL] [Abstract][Full Text] [Related]
25. [Percutaneous closure of patent foramen ovale: a wise approach].
Gaspardone A; Iani C; Papa M
G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
[TBL] [Abstract][Full Text] [Related]
26. The IrisFIT Patent Foramen Ovale Closure Device in Patients With History of Cryptogenic Embolization.
Hornung M; Bertog SC; Gafoor S; Reinartz M; Vaskelyte L; Hofmann I; Sievert K; Matic P; Grunwald I; Sievert H
J Invasive Cardiol; 2019 Nov; 31(11):319-324. PubMed ID: 31522140
[TBL] [Abstract][Full Text] [Related]
27. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.
Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L;
Stroke; 2010 Dec; 41(12):2872-83. PubMed ID: 21051670
[TBL] [Abstract][Full Text] [Related]
28. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
[TBL] [Abstract][Full Text] [Related]
29. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
30. Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke.
Kim M; Kim S; Moon J; Oh PC; Park YM; Shin DH; Lee YB; Lee JY; Hwang HY; Kang WC
J Interv Cardiol; 2018 Jun; 31(3):368-374. PubMed ID: 28833599
[TBL] [Abstract][Full Text] [Related]
31. HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicentre experience.
Billinger K; Ostermayer SH; Carminati M; Degiovanni JV; Ewert P; Hess J; Maymone-Martins FA; Qureshi SA; Salmon AP; Schneider M; Wilson N; Sievert H
EuroIntervention; 2006 Feb; 1(4):465-71. PubMed ID: 19755222
[TBL] [Abstract][Full Text] [Related]
32. Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure.
Lantz M; Kostulas K; Settergren M; Sjöstrand C
J Interv Cardiol; 2017 Jun; 30(3):242-248. PubMed ID: 28439982
[TBL] [Abstract][Full Text] [Related]
33. Recurrent Stroke after Transcatheter PFO Closure in Cryptogenic Stroke or Tia: Long-Term Follow-Up.
Mariucci E; Donti A; Salomone L; Marcia M; Guidarini M; Formigari R; Prandstraller D; Balducci A; Bronzetti G; Bonvicini M
Cardiol Res Pract; 2017; 2017():9849425. PubMed ID: 29430320
[TBL] [Abstract][Full Text] [Related]
34. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
[TBL] [Abstract][Full Text] [Related]
35. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
[TBL] [Abstract][Full Text] [Related]
37. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
[TBL] [Abstract][Full Text] [Related]
38. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes after percutaneous patent foramen ovale closure.
Nagpal SV; Lerakis S; Flueckiger PB; Halista M; Willis P; Block PC; Douglas JS; Morris DC; Liff DA; Stewart J; Devireddy C; Veledar E; Nahab FB; Babaliaros VC
Am J Med Sci; 2013 Sep; 346(3):181-6. PubMed ID: 23328836
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
